Compare CDNA & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | EPAC |
|---|---|---|
| Founded | 1998 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2007 | 1994 |
| Metric | CDNA | EPAC |
|---|---|---|
| Price | $45.88 | $37.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $28.00 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 1.3M | 551.5K |
| Earning Date | 04-28-2026 | 03-25-2026 |
| Dividend Yield | N/A | ★ 0.12% |
| EPS Growth | N/A | ★ 8.97 |
| EPS | ★ 2.13 | 1.24 |
| Revenue | $48,324,000.00 | ★ $616,899,000.00 |
| Revenue This Year | $16.01 | $5.60 |
| Revenue Next Year | $11.31 | $5.56 |
| P/E Ratio | ★ $21.04 | $30.21 |
| Revenue Growth | ★ 18.93 | 4.65 |
| 52 Week Low | $11.27 | $32.35 |
| 52 Week High | $49.76 | $45.00 |
| Indicator | CDNA | EPAC |
|---|---|---|
| Relative Strength Index (RSI) | 71.17 | 60.41 |
| Support Level | $16.70 | $36.79 |
| Resistance Level | N/A | $37.57 |
| Average True Range (ATR) | 2.18 | 0.82 |
| MACD | 0.61 | 0.25 |
| Stochastic Oscillator | 66.44 | 94.89 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Enerpac Tool Group Corp provides high-precision hydraulic and mechanical tools, controlled-force products, and heavy lifting solutions. Operating mainly through its Industrial Tools & Services (IT&S) segment, the company designs, manufactures, and distributes branded tools, and offers maintenance, bolting, machining, joint integrity, and equipment rental services across industries such as oil & gas, manufacturing, power generation, and infrastructure. Its key products include hydraulic cylinders, pumps, torque wrenches, and bolt tensioners under the brands ENERPAC and HYDRATIGHT. The company serves customers internationally, with operations in the USA, Australia, Brazil, Germany, Saudi Arabia, the United Kingdom, and other countries, deriving the majority of its revenue from the USA.